Alexey Kozlenkov

Dr. Alexey Kozlenkov

Icahn School of Medicine at Mount Sinai, New York, United States

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
AKAlexey Kozlenkov
Alexey Kozlenkov
JLJunhao Li
Junhao Li
PAPasha Apontes
Pasha Apontes
YHYasmin L. Hurd
Yasmin L. Hurd
WBWilliam M. Byne
William M. Byne
SDStella Dracheva
Stella Dracheva
DNA hydroxymethylation is a distinctive epigenetic regulator of human inhibitory neurons, potentially affecting brain diseases.

30 May 2017 in Genes
Verified
Journal Article
Open access
PDF file
AKAlexey Kozlenkov
Alexey Kozlenkov
AJAndrew E. Jaffe
Andrew E. Jaffe
ATAlisa Timashpolsky
Alisa Timashpolsky
PAPasha Apontes
Pasha Apontes
SRSergei Rudchenko
Sergei Rudchenko
SDStella Dracheva
Stella Dracheva
We employed Illumina 450 K Infinium microarrays to profile DNA methylation (DNAm) in neuronal nuclei separated by fluorescence-activated sorting from the postmortem orbitofrontal cortex (OFC) of heroin users who died from heroin overdose (N = 37), suicide completers (N = 22) with no evidence of heroin use and from control subjects who did not abuse illicit drugs and died of non-suicide causes (N = 28). We identified 1298 differentially methylated CpG sites (DMSs) between heroin users and controls, and 454 DMSs between suicide completers and controls (p < 0.001). DMSs and corresponding genes (DMGs) in heroin users showed significant differences in the preferential context of hyper and hypo DM. HyperDMSs were enriched in gene bodies and exons but depleted in promoters, whereas hypoDMSs were enriched in promoters and enhancers. In addition, hyperDMGs showed preference for genes expressed specifically by glutamatergic as opposed to GABAergic neurons and enrichment for axonogenesis- and synaptic-related gene ontology categories, whereas hypoDMGs were enriched for transcription factor activity- and gene expression regulation-related terms. Finally, we found that the DNAm-based “epigenetic age” of neurons from heroin users was younger than that in controls. Suicide-related results were more difficult to interpret. Collectively, these findings suggest that the observed DNAm differences could represent functionally significant marks of heroin-associated plasticity in the OFC.

15 September 2023 in Glia
Verified
Journal Article
Closed access
AKAlexey Kozlenkov
Alexey Kozlenkov
RVRamu Vadukapuram
Ramu Vadukapuram
PZPing Zhou
Ping Zhou
PFPeter Fam
Peter Fam
MWMichael Wegner
Michael Wegner
SDStella Dracheva
Stella Dracheva

17 November 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
JLJunhao Li
Junhao Li
MJManoj K Jaiswal
Manoj K Jaiswal
JCJo-Fan Chien
Jo-Fan Chien
AKAlexey Kozlenkov
Alexey Kozlenkov
PZPing Zhou
Ping Zhou
SDStella Dracheva
Stella Dracheva
Neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), are strongly influenced by inherited genetic variation, but environmental and epigenetic factors also play key roles in the course of these diseases. A hexanucleotide repeat expansion in the C9orf72 (C9) gene is the most common genetic cause of ALS and FTD. To determine the cellular alterations associated with the C9 repeat expansion, we performed single nucleus transcriptomics (snRNA-seq) and epigenomics (snATAC-seq) in postmortem samples of motor and frontal cortices from C9-ALS and C9-FTD donors. We found pervasive alterations of gene expression across multiple cortical cell types in C9-ALS, with the largest number of affected genes in astrocytes and excitatory neurons. Astrocytes increased expression of markers of activation and pathways associated with structural remodeling. Excitatory neurons in upper and deep layers increased expression of genes related to proteostasis, metabolism, and protein expression, and decreased expression of genes related to neuronal function. Epigenetic analyses revealed concordant changes in chromatin accessibility, histone modifications, and gene expression in specific cell types. C9-FTD patients had a distinct pattern of changes, including loss of neurons in frontal cortex and altered expression of thousands of genes in astrocytes and oligodendrocyte-lineage cells. Overall, these findings demonstrate a context-dependent molecular disruption in C9-ALS and C9-FTD, resulting in distinct effects across cell types, brain regions, and disease phenotypes. One Sentence Summary: C9orf72-associated ALS and FTD showed a distinct pattern of transcriptome changes, with the largest number of affected genes in C9-ALS in astrocytes and excitatory neurons in upper and deep layers.

6 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CTCarlos A Toro
Carlos A Toro
NJNicholas P Johnson
Nicholas P Johnson
ZSZaraa Suhail
Zaraa Suhail
RCRuiwen Chen
Ruiwen Chen
JLJohn T. Leman
John T. Leman
MSMustafa M Siddiq
Mustafa M Siddiq
We demonstrate for the first time that the natural antioxidant curcumin, when copolymerized with PEG and sebacoyl chloride, results in biomaterials that are solution processable into free-standing, epidurally implantable thin films, in mice with spinal cord injury (SCI). We show that these novel products can be epidurally implanted at the lesion site following incomplete contusive spinal cord injury in mice. In the polymeric form, these materials quench reactive oxygen species on-contact and retain their activity for vastly extended timescales relative to the curcumin small molecule itself, which is potent but short lived. The epidural thin film biomaterial implant resulted in a statistically significant improvement in functional recovery after SCI. Mechanistically, myelin staining revealed that the polymerized curcumin materials greatly enhanced white matter sparing. Immunohistochemical analysis also showed that expression of GFAP and Ib1a are significantly downregulated 200 µm rostral (but not caudal) to the injury site. Finally, bulk RNA sequencing analysis showed greatly reduced activation of pro-inflammatory gene expression program. The primary conclusion from these experiments is that polymerized curcumin epidural thin films effectively improve outcomes following SCI. The benefits of these novel biomaterials are demonstrated in vivo , for the first time, and suggest that poly(pro-drug) thin film implants may provide safe chronic, local delivery of active drugs following SCI for extended timescales.

15 October 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
JPJiangping Pan
Jiangping Pan
SKShahrukh Khalique
Shahrukh Khalique
AKAlexey Kozlenkov
Alexey Kozlenkov
CTCarlos A. Toro
Carlos A. Toro
CCChristopher Cardozo
Christopher Cardozo
WZWei Zhao
Wei Zhao
Background/Objectives: Neuropathic pain is a complex chronic disorder affecting roughly 7–10% of the population. Current neuropathic pain treatments fail to provide adequate relief in at least ~40% of patients and are usually accompanied by side effects that are sometimes severe. In this study, we investigated the effect of boldine, a natural occurring alkaloid, in attenuating peripheral nerve injury-induced neuropathic pain symptoms and transcriptomic changes. Methods: Male C57BL6 mice underwent chronic constriction injury (CCI) to the sciatic nerve. Customized diet containing boldine or control diet was administered immediately after surgery. Mechanical pain responses were measured by Von Frey filament test. Spontaneous pain-like weight bearing behavior was assessed using the dynamic weight bearing system. L3–L5 spinal cords were collected 15 days after injury and subjected to quantitative PCR and bulk RNA sequencing. Results: CCI led to ipsilateral hypersensitivity of mechanical pain responses and weight-bearing deficits including reduced rearing duration, ipsilateral/contralateral weight support ratio, and ipsilateral hind paw posed duration. Boldine treatment substantially attenuated CCI-induced mechanical allodynia but not the weight bearing deficits. Gene expression analysis showed that boldine inhibited CCI-induced upregulation of inflammatory mediators in the spinal cord. RNA sequencing analysis revealed several pain-related canonical pathways and upstream factors after CCI, and boldine treatment markedly reversed these CCI-induced transcriptomic changes. Conclusions: Early oral administration of boldine attenuated CCI-induced mechanical allodynia and was associated with reduced inflammatory gene expression and reversal of multiple injury-related transcriptomic changes in the spinal cord. These preliminary preclinical findings support further investigation of boldine and do not establish therapeutic efficacy in established neuropathic pain.